Dyne Therapeutics shared new one-year ACHIEVE trial data for z-basivarsen (DYNE-101) in #myotonicDystrophy type 1 (DM1), reporting improvements in function, strength, myotonia, and participant-reported symptoms. Read Dyne’s letter to the DM community at: www.dyne-tx.com/new-one-year...